✦ LIBER ✦

Phase II studies of topotecan in patients with non-small cell lung cancer (NSCLC) previously untreated and patients with small cell lung (SCLC) cancer refractory to etoposide

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Etoposide in patients with previously un

✍ N. Niederle; J. Ostermann; W. Achterrath; L. Lenaz; C. G. Schmidt 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 456 KB

Etoposide in patients with previously un

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Etoposide and high dose carboplatin in p

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Phase II study of gemcitabine + Vindesin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB